Education
About Us
Working with TipRanks
Follow Us
Tiziana Life Sciences Plc (TLSA)
NASDAQ:TLSA
Total Valuation
Tiziana Life Sciences has a market cap or net worth of $118.41M. The enterprise value is .
Market Cap$118.41M
Enterprise Value
Share Statistics
Tiziana Life Sciences has 110.66M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding110.66M
Owned by Insiders
Owned by Instutions0.09%
Financial Efficiency
Tiziana Life Sciences’s return on equity (ROE) is -3.20 and return on invested capital (ROIC) is -319.08%.
Return on Equity (ROE)-319.56%
Return on Assets (ROA)-145.20%
Return on Invested Capital (ROIC)-319.08%
Return on Capital Employed (ROCE)-318.58%
Revenue Per Employee$0
Profits Per Employee-$1,209,333.333
Employee Count9
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Tiziana Life Sciences is 0.00. Tiziana Life Sciences’s PEG ratio is 0.00.
PE Ratio0.00
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.00
Income Statement
In the last 12 months, Tiziana Life Sciences had revenue of $0.00 and earned -$10.88M in profits. Earnings per share was -$0.11.
Revenue$0.00
Gross Profit-$46.00K
Operating Income-$10.04M
Pretax Income-$10.88M
Net Income-$10.88M
EBITDA-10.83M
Earnings Per Share (EPS)-0.11
Cash Flow
In the last 12 months, operating cash flow was -$7.70M and capital expenditures $0.00, giving a free cash flow of -$7.70M billion.
Operating Cash Flow-$7.70M
Free Cash Flow-$7.70M
Free Cash Flow per Share-$0.07
Dividends & Yields
Tiziana Life Sciences pays an annual dividend of $0.03, resulting in a dividend yield of
Dividend Per Share$0.03
Dividend Yield
Payout Ratio
Free Cash Flow Yield0.00%
Earnings Yield―
Stock Price Statistics
Beta-0.73
52-Week Price Change42.67%
50-Day Moving Average1.07
200-Day Moving Average0.97
Relative Strength Index (RSI)53.22
Average Volume (3m)530.07K
Important Dates
Tiziana Life Sciences upcoming earnings date is Sep 27, 2023, TBA.
Last Earnings DateMay 23, 2023
Next Earnings DateSep 27, 2023
Ex-Dividend DateJul 9, 2021
Financial Position
Tiziana Life Sciences as a current ratio of 1.12, with Debt / Equity ratio of 0.04
Current Ratio1.12
Quick Ratio1.12
Debt to Market Cap0.00
Net Debt to EBITDA0.05
Interest Coverage Ratio-1.80K
Taxes
In the past 12 months, Tiziana Life Sciences has paid $0.00 in taxes.
Income Tax$0.00
Effective Tax Rate-2.60%
Enterprise Valuation
Tiziana Life Sciences EV to EBITDA ratio is 0.05, with an EV/FCF ratio of 0.06.
EV to Sales0.00
EV to EBITDA0.05
EV to Free Cash Flow0.06
EV to Operating Cash Flow0.06
Balance Sheet
Tiziana Life Sciences has $18.12M in cash and marketable securities with $122.00K in debt, giving a net cash position of -$18.00M billion.
Cash & Marketable Securities$18.12M
Total Debt$122.00K
Net Cash-$18.00M
Net Cash Per Share-$0.16
Tangible Book Value Per Share$0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Tiziana Life Sciences is , which is 11.43% higher than the current price. The consensus rating is
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast